Czechia vs Lebanon: The number of people with susceptibility test result for rifampicin
Czechia
239
in 2021
Lebanon
228
in 2021
Czechia rank
90th
Lebanon rank
91st
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Lebanon
How they compare
Czechia currently reports 239 against 228 in Lebanon, a difference of 11.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Czechia ahead.
Czechia ranks 90th and Lebanon ranks 91st of 155 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 294 | 331.33 | 37.33 | Lebanon |
| 2020s | 231 | 277.5 | 46.5 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Lebanon?
- Czechia, at 239 against 228 in Lebanon as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Lebanon?
- 11, with Czechia ahead.
- How many years of comparable data are there for Czechia and Lebanon?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Lebanon rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 90th and Lebanon ranks 91st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.